These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23299559)

  • 21. Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.
    Conteh L; Patouillard E; Kweku M; Legood R; Greenwood B; Chandramohan D
    PLoS One; 2010 Aug; 5(8):e12223. PubMed ID: 20808923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost and cost-effectiveness of an enhanced intervention for people with substance abuse problems at risk for HIV.
    Zarkin GA; Lindrooth RC; Demiralp B; Wechsberg W
    Health Serv Res; 2001 Jun; 36(2):335-55. PubMed ID: 11409816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease.
    Hopkins RB; Garg AX; Levin A; Molzahn A; Rigatto C; Singer J; Soltys G; Soroka S; Parfrey PS; Barrett BJ; Goeree R
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1248-57. PubMed ID: 21617091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micro-costing in public health economics: steps towards a standardized framework, using the incredible years toddler parenting program as a worked example.
    Charles JM; Edwards RT; Bywater T; Hutchings J
    Prev Sci; 2013 Aug; 14(4):377-89. PubMed ID: 23306596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple imputation methods for handling missing data in cost-effectiveness analyses that use data from hierarchical studies: an application to cluster randomized trials.
    Gomes M; Díaz-Ordaz K; Grieve R; Kenward MG
    Med Decis Making; 2013 Nov; 33(8):1051-63. PubMed ID: 23913915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Economic evaluation of public health interventions].
    García-Altés A; Navas E; Soriano MJ
    Gac Sanit; 2011 Jun; 25 Suppl 1():25-31. PubMed ID: 22055548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collecting costs of community prevention programs: communities putting prevention to work initiative.
    Khavjou OA; Honeycutt AA; Hoerger TJ; Trogdon JG; Cash AJ
    Am J Prev Med; 2014 Aug; 47(2):160-5. PubMed ID: 24746039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.
    Marseille E; Dandona L; Marshall N; Gaist P; Bautista-Arredondo S; Rollins B; Bertozzi SM; Coovadia J; Saba J; Lioznov D; Du Plessis JA; Krupitsky E; Stanley N; Over M; Peryshkina A; Kumar SG; Muyingo S; Pitter C; Lundberg M; Kahn JG
    BMC Health Serv Res; 2007 Jul; 7():108. PubMed ID: 17626616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study.
    Bórquez A; Guanira JV; Revill P; Caballero P; Silva-Santisteban A; Kelly S; Salazar X; Bracamonte P; Minaya P; Hallett TB; Cáceres CF
    Lancet Public Health; 2019 Mar; 4(3):e127-e136. PubMed ID: 30683587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resource consumption of a diffusion model for prevention programs: the PROSPER delivery system.
    Crowley DM; Jones DE; Greenberg MT; Feinberg ME; Spoth RL
    J Adolesc Health; 2012 Mar; 50(3):256-63. PubMed ID: 22325131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness and cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs: a systematic review and economic evaluation.
    Hayhurst KP; Leitner M; Davies L; Flentje R; Millar T; Jones A; King C; Donmall M; Farrell M; Fazel S; Harris R; Hickman M; Lennox C; Mayet S; Senior J; Shaw J
    Health Technol Assess; 2015 Jan; 19(6):1-168, vii-viii. PubMed ID: 25619533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.
    Palmer AJ; Roze S; Valentine WJ; Spinas GA; Shaw JE; Zimmet PZ
    Clin Ther; 2004 Feb; 26(2):304-21. PubMed ID: 15038953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic analyses of the Be Fit Be Well program: a weight loss program for community health centers.
    Ritzwoller DP; Glasgow RE; Sukhanova AY; Bennett GG; Warner ET; Greaney ML; Askew S; Goldman J; Emmons KM; Colditz GA;
    J Gen Intern Med; 2013 Dec; 28(12):1581-8. PubMed ID: 23733374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study.
    Marshall A; Altman DG; Royston P; Holder RL
    BMC Med Res Methodol; 2010 Jan; 10():7. PubMed ID: 20085642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining multiple imputation and bootstrap in the analysis of cost-effectiveness trial data.
    Brand J; van Buuren S; le Cessie S; van den Hout W
    Stat Med; 2019 Jan; 38(2):210-220. PubMed ID: 30207407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic costs, health-related quality of life outcomes and cost-utility of a physical and psychological group intervention targeted at older adults with neurogenic claudication.
    Maredza M; Khan K; Marian IR; Dutton SJ; Williamson E; Lamb SE; Petrou S
    Cost Eff Resour Alloc; 2023 Feb; 21(1):14. PubMed ID: 36755265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple imputation for non-response when estimating HIV prevalence using survey data.
    Chinomona A; Mwambi H
    BMC Public Health; 2015 Oct; 15():1059. PubMed ID: 26475303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.